Sort
10,766 grants matching “checkpoint inhibitor”
Identification of the mechanism by which Toxoplasma activates the NLRP1 inflammasome
$235,500Jeroen Saeij · University Of California At Davis · R21 · FY2020 · AI
ATM (Ataxia Telangiectasia Mutated) signaling through cyclin D1
$235,500Masahiro Hitomi · Cleveland Clinic Lerner Com-Cwru · R21 · FY2010 · NS
Ménage à trois - Zika virus, DNA damage responses and microcephaly; is PNKP the molecular link?
$235,500Luis M. Schang · Cornell University · R21 · FY2020 · NS
Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapy
$235,417Theresa Guo · University Of California, San Diego · K08 · FY2024 · CA
Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapy
$235,417Theresa Guo · University Of California, San Diego · K08 · FY2025 · CA
Transcriptional silencing by the BCL6 oncoprotein
$235,282Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · CA
Project 1: 5FU and Vitamin D as Neoadjuvants for Photodynamic Priming to Enhance Skin Cancer Therapy
$234,921Edward V. Maytin · Massachusetts General Hospital · P01 · FY2023 · CA
Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
$234,919Samuel G Katz · Yale University · R21 · FY2023 · CA
Integrin-Linked Kinase in Papillary Thyroid Cancer-Associated Fibroblasts and the Tumor Microenvironment
$234,909Lawrence Andrew Shirley · Ohio State University · K08 · FY2019 · CA
Systemic/Abscopal Anti-Tumor Immune Responses during IAP Antagonism and Radiation
$234,750Nicole Cherie Schmitt · Emory University · R21 · FY2025 · DE
Targeting Tumor-Associated Macrophages via Hedgehog Inhibition to Enhance Immunotherapy in Non-Small Cell Lung Cancer
$234,749Dwight H. Owen · Ohio State University · R21 · FY2025 · CA
Development of Sapacitabine Therapy in Leukemias
$234,723William K Plunkett · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
SPORE: Targeted Therapies for Glioma
$234,721Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
$234,675St. Jude Children'S Research Hospital · R01 · FY2001 · CA
Tissue-based predictive biomarkers for Cabozantinib therapy in metastatic renal cell carcinoma
$234,596Sabina Signoretti · Brigham And Women'S Hospital · R21 · FY2020 · CA
Core B: Biological Models, Multiplexed Optical Biopsy, Molecular Pathology, and Biostatistics Core
$234,559Bryan Quilty Spring · Massachusetts General Hospital · P01 · FY2023 · CA
Ultralong CDR3 antibodies targeting exhausted T cells
$234,525Vaughn Vasil Smider · Applied Biomedical Science Institute · R21 · FY2021 · AI
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
$234,234Timothy C Chambers · Univ Of Arkansas For Med Scis · R01 · FY2010 · CA
Utilizing Multi-omics to Facilitate Cancer Biology Research
$233,684Alex Lee · University Of California, San Francisco · R50 · FY2025 · CA
Utilizing Multi-omics to Facilitate Cancer Biology Research
$233,657Alex Lee · University Of California, San Francisco · R50 · FY2024 · CA
Utilizing Multi-omics to Facilitate Cancer Biology Research
$233,631Alex Lee · University Of California, San Francisco · R50 · FY2023 · CA
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
$233,626St. Jude Children'S Research Hospital · R01 · FY2000 · CA
RAPAMYCIN INDUCED SELECTIVE APOPTOSIS IN MALIGNANT CELLS
$233,582St. Jude Children'S Research Hospital · R01 · FY2001 · CA
Project 3: Predictors of sensitivity to immunotherapy and targeted treatments based on real world evidence
$233,452Nikolaus Schultz · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA
Dietary methionine restriction as a therapeutic strategy for metastatic melanoma
$233,347Isabelle Racine Miousse · University Of Arkansas At Fayetteville · P20 · FY2024 · GM